Wockhardt is evolving! 🚀 Moving from generics to a global, research-driven powerhouse in novel antibiotics and biotech (diabetes). 🧬
Global reach: ~70% revenue outside India 🌍
Innovation focus: ~18% of sales from research-led segments 🔬
Global reach: ~70% revenue outside India 🌍
Innovation focus: ~18% of sales from research-led segments 🔬
Trade closed: target reached
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.